71636-62-9
71636-62-9
Chemical Structure
SKF-80723
- CAS No.: 71636-62-9
- Formula:C16H16BrNO2
- Molecular Weight:334.21
IUPAC Name: 6-bromo-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol
InChIKey: XKTGLDSNABUNGD-UHFFFAOYSA-N
SMILES: OC1=C(O)C=C2C(C3=CC=CC=C3)CNCCC2=C1Br
Biological Activity: SKF-80723 is a D1 receptor agonist and can be used for study of Parkinson's disease[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SKF-80723 | SKF-80723 is a D1 receptor agonist and can be used for study of Parkinson's disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Gnanalingham KK, et al. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate. Psychopharmacology (Berl). 1995;117(4):403-412. [Content Brief]
- [2]. Gnanalingham KK, et al. The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease. Psychopharmacology (Berl). 1995;117(3):287-297. [Content Brief]
Keywords
